NIH-funded research R01 grant

Understanding how GPX3 affects Eosinophilic Esophagitis

Official title: Defining the role of GPX3 in Eosinophilic Esophagitis

Funded at Vanderbilt University Medical Center · NIH-11026148 · Data updated 2026-11-12

This study is looking at how a protein called GPX3 affects Eosinophilic Esophagitis (EoE), a condition that causes inflammation in the esophagus, to help find new ways to treat it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startMarch 15, 2025
Project endJanuary 31, 2030
Funding year2025
Award (this year)$650,614
NIH project number1R01DK141803-01
Project IDNIH-11026148 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Eosinophilic Esophagitis, particularly children and adults experiencing symptoms.

Less likely to help

Patients without Eosinophilic Esophagitis or those with other unrelated esophageal conditions may not benefit from this research.

What this research studies

This research investigates the role of Glutathione Peroxidase 3 (GPX3) in Eosinophilic Esophagitis (EoE), a condition characterized by inflammation and damage to the esophagus. The study focuses on how GPX3 regulates the balance of reactive oxygen species, which are crucial for maintaining healthy esophageal tissue. By examining both human samples and animal models, the research aims to uncover the mechanisms by which GPX3 influences esophageal remodeling and eosinophil recruitment, potentially leading to new therapeutic strategies for EoE.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from Eosinophilic Esophagitis.

How similar studies have gone: Previous research has shown promising results in understanding the role of oxidative stress in EoE, suggesting that this approach could yield significant insights.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Choksi, Yash — Vanderbilt University Medical Center
  • Study coordinator: Choksi, Yash

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.